title: Voice disorders induced by bevacizumab administration in an ovarian cancer patient: an underestimated and rare toxicity.
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus. Electronic address: pantkount@gmail.com.
authors: P
authors: P
authors: Kountourakis
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: G
authors: G
authors: Antoniou
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: K
authors: K
authors: Papadimitriou
authors: Radiation Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: V
authors: V
authors: Vassiliou
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: D
authors: D
authors: Syrigos
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: M
authors: M
authors: Philippou
authors: Medical Oncology Department, B.O.C. Oncology Centre, Nicosia, Cyprus.
authors: D
authors: D
authors: Papamichael
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000150:complications / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000098:blood supply / Q000150:complications / Q000188:drug therapy*; D010053:Ovary / Q000098:blood supply / Q000187:drug effects; D014827:Vocal Cords / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D014832:Voice Disorders / Q000139:chemically induced* / Q000150:complications / Q000473:pathology
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab